We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+6.91%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$723M
AUM Growth
+$88.9M
(+14%)
Cap. Flow
+$56.1M
Cap. Flow
% of AUM
7.77%
Top 10 Holdings %
Top 10 Hldgs %
33.83%
Holding
1,372
New
165
Increased
391
Reduced
364
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$22.2M |
| 2 |
Invesco NASDAQ 100 ETF
QQQM
|
+$21.9M |
| 3 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$21.8M |
| 4 |
iShares S&P Small-Cap 600 Growth ETF
IJT
|
+$21.8M |
| 5 |
Schwab US TIPS ETF
SCHP
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$93.4M |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$20M |
| 3 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$4.36M |
| 4 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$2.46M |
| 5 |
Vanguard Morningstar Mid-Cap Value ETF
VOE
|
+$2.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.06% |
| 2 | Healthcare | 2.35% |
| 3 | Financials | 1.65% |
| 4 | Consumer Discretionary | 1.28% |
| 5 | Industrials | 1.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Merck
MRK
$316B
| $555K | 0.08% |
5,005
+435
| +10% | +$44.5K |
|
|
102
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
| $545K | 0.08% |
5,959
-1,020,288
| -99% | -$93.4M |
|
103
Nucor
NUE
$59.5B
| $541K | 0.07% |
4,103
+15
| +0.4% | +$2.04K |
|
104
Danaher
DHR
$139B
| $539K | 0.07% |
2,291
-20
| -0.9% | -$4.64K |
|
105
Procter & Gamble
PG
$338B
| $526K | 0.07% |
3,474
-2,236
| -39% | -$313K |
|
106
Thermo Fisher Scientific
TMO
$212B
| $516K | 0.07% |
938
+66
| +8% | +$35K |
|
107
Accenture
ACN
$101B
| $499K | 0.07% |
1,870
-4
| -0.2% | -$1.11K |
|
108
Broadcom
AVGO
$1.87T
| $494K | 0.07% |
8,830
-20
| -0.2% | -$1K |
|
109
Blackstone
BX
$108B
| $493K | 0.07% |
6,645
-100
| -1% | -$8.64K |
|
110
Cencora
COR
$60B
| $480K | 0.07% |
2,895
+112
| +4% | +$17.7K |
|
111
PepsiCo
PEP
$191B
| $475K | 0.07% |
2,631
+6
| +0.2% | +$1.07K |
|
112
Vanguard S&P 500 ETF
VOO
$993B
| $454K | 0.06% |
1,292
-178
| -12% | -$62.9K |
|
113
TransDigm Group
TDG
$71.9B
| $453K | 0.06% |
719
+12
| +2% | +$7.07K |
|
114
CDW
CDW
$18.9B
| $446K | 0.06% |
2,497
-999
| -29% | -$176K |
|
115
Innovator US Equity Buffer ETF July
BJUL
$349M
| $446K | 0.06% |
14,418
+1,673
| +13% | +$51.5K |
|
116
Intuitive Surgical
ISRG
$133B
| $443K | 0.06% |
1,668
-176
| -10% | -$42.9K |
|
117
Nike
NKE
$63.3B
| $438K | 0.06% |
3,741
-42
| -1% | -$4.23K |
|
118
Innovator US Equity Power Buffer ETF September
PSEP
$845M
| $430K | 0.06% |
14,704
+451
| +3% | +$13.1K |
|
119
First Trust Dorsey Wright Focus 5 ETF
FV
$3.64B
| $426K | 0.06% |
9,148
-38
| -0.4% | -$1.77K |
|
120
Innovator US Equity Buffer ETF August
BAUG
$197M
| $424K | 0.06% |
14,158
-120
| -0.8% | -$3.59K |
|
121
Innovator US Equity Buffer ETF November
BNOV
$212M
| $417K | 0.06% |
13,997
+569
| +4% | +$16.9K |
|
122
Innovator US Equity Power Buffer ETF November
PNOV
$889M
| $414K | 0.06% |
13,698
+932
| +7% | +$27.9K |
|
123
Innovator US Equity Buffer ETF March
BMAR
$252M
| $413K | 0.06% |
12,824
-100
| -0.8% | -$3.19K |
|
124
Innovator US Equity Buffer ETF February
BFEB
$256M
| $408K | 0.06% |
13,628
-120
| -0.9% | -$3.55K |
|
125
Synopsys
SNPS
$75.1B
| $407K | 0.06% |
1,276
-7
| -0.5% | -$2.19K |
|
Similar funds
TYCC
TH
ACA
BCP
WWA
VPC
BPS
TCM
Arax Advisory Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Arax Advisory Partners held 1,372 positions worth $723M, up 14% from $634M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Arax Advisory Partners deployed $56.1M of net new capital in Q4 2022, opening 165 new positions and adding to 391 existing holdings. Its largest new stake was iShares S&P Small-Cap 600 Value ETF: 236,971 shares worth $21.6M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $93.4M trimmed.
- Arax Advisory Partners's largest Q4 2022 buy was iShares S&P Small-Cap 600 Value ETF: 236,971 shares worth $21.6M.
- Arax Advisory Partners added most to iShares S&P Mid-Cap 400 Growth ETF in Q4 2022, an estimated $22.2M increase.
- Arax Advisory Partners's biggest Q4 2022 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $93.4M.
- Arax Advisory Partners fully exited Alleghany Corp in Q4 2022, selling an estimated $95K.
- Arax Advisory Partners's ten largest holdings make up 34% of its $723M portfolio in Q4 2022.
- Arax Advisory Partners opened 165 new positions and closed 101 in Q4 2022.
- Arax Advisory Partners's portfolio value rose 14% quarter-over-quarter to $723M.
Based on Arax Advisory Partners's 13F filing for Q4 2022, filed 24 Feb 2023.